United States · Bill · HR
H.R. 6946 (117th)
SAFE Act of 2022
Introduced
7 March 2022
Last action
1 November 2022 · Referred
Status
Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
Sponsors
Rep. Pappas, Chris [D-NH-1], Rep. Newhouse, Dan [R-WA-4], Sen. Budd, Ted [R-NC], Rep. Suozzi, Thomas R. [D-NY-3], Rep. Van Drew, Jefferson [R-NJ-2], Rep. Cuellar, Henry [D-TX-28], Rep. Roybal-Allard, Lucille [D-CA-40], Rep. Craig, Angie [D-MN-2], Rep. Spanberger, Abigail Davis [D-VA-7], Rep. Gonzales, Tony [R-TX-23], Rep. Bacon, Don [R-NE-2]
Subjects
Discovery layer
Source updated
11 July 2026
Summary
Save Americans from the Fentanyl Emergency Act of 2022 or the SAFE Act of 2022 This bill permanently places fentanyl-related substances as a class into schedule I of the Controlled Substances Act. A schedule I controlled substance is a drug, substance, or chemical that has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act. It limits the application of mandatory minimum penalties for certain offenses involving fentanyl-related substances, establishes a process to deschedule or remove certain fentanyl-related substances that have a low potential for abuse, and allows a federal court to vacate or reduce the sentence for convictions of offenses involving a fentanyl-related substance that is descheduled or moved to a schedule other than schedule I or II. The bill establishes a new, alternative registration process for schedule I research. It also makes other changes to registration requirements for conducting research with controlled substances, including permitting a single registration for related research sites in certain circumstances, waiving the requirement for a new inspection in certain situations, and allowing a registered researcher to perform certain manufacturing activities with small quantities of a substance without obtaining a manufacturing registration. Finally, the bill requires the Government Accountability Office to analyze the implementation and impact of permanently placing fentanyl-related substances into schedule I of the Controlled Substances Act.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
7 March 2022
Introduced
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Source: IntroReferral
7 March 2022
Introduced
Introduced in House
Source: IntroReferral
7 March 2022
Introduced
Introduced in House
Source: IntroReferral
8 March 2022
Referred
Referred to the Subcommittee on Health.
Source: Committee
1 November 2022
Referred
Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
Source: Committee
Votes
No vote records are attached yet.
Versions
- Introduced in House · 7 March 2022 · Download file
Documents
3 official files
Introduced in House (text)
This file cannot be previewed here. Use View or Download.
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Introduced in House (text)
Introduced in House · EN · 7 March 2022
Introduced in House (PDF)
Introduced in House · EN · 7 March 2022
ViewDownloadOpen at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Introduced in House
summary · EN · 7 March 2022
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Sponsors
- Rep. Pappas, Chris [D-NH-1] · D · Sponsor
- Rep. Newhouse, Dan [R-WA-4] · R · Sponsor
- Sen. Budd, Ted [R-NC] · R · Sponsor
- Rep. Suozzi, Thomas R. [D-NY-3] · D · Cosponsor
- Rep. Van Drew, Jefferson [R-NJ-2] · R · Cosponsor
- Rep. Cuellar, Henry [D-TX-28] · D · Cosponsor
- Rep. Roybal-Allard, Lucille [D-CA-40] · D · Cosponsor
- Rep. Craig, Angie [D-MN-2] · D · Cosponsor
- Rep. Spanberger, Abigail Davis [D-VA-7] · D · Cosponsor
- Rep. Gonzales, Tony [R-TX-23] · R · Cosponsor
- Rep. Bacon, Don [R-NE-2] · R · Cosponsor
- · hsju00 · Standing
- · hsif00 · Standing
Related records
- related to → SAFE Act
- related to → Federal Initiative To Guarantee Health by Targeting Fentanyl Act
- related to → CEASE Overdose Act of 2022
- related to → SAFE Act
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/117th-congress/house-bill/6946
- Open data entity: https://api.congress.gov/v3/bill/117/hr/6946
- us · 117-hr-6946 · source updated 11 July 2026